Latest Articlesddd
The FDA announced what made Clovis Oncology (CLVS) shareholders believe that the bad times might have …
Xoma’s (XOMA) webcast and conference call scheduled for September 15, 2016, at 1:30 p.m. PDT (4:30 …
Filled with high hopes and great enthusiasm, we are following up on Nektar’s (NKTR) immunotherapy product …
At the European Society of Cardiology Congress 2016 in Rome, Italy, Array Biopharma (ARRY) presented good …
Benign Prostate Hypertrophy (BPH) Is Fexapotide the Safest and Effective Prostate Cancer Preventative? That’s what Nymox …
Pfizer accepted to pay $14 billion in cash to acquire Medivation. It is important for investors …
AMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women with Osteoporosis The Company is Radius …
Advaxis (ADXS) is a small clinical-stage biotech producing and developing cancer immunotherapy products based on its …
JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women with Osteoporosis The Company is …
What’s Going on the Morning of Thursday, August 18, 2016? PORTOLA Portola Pharmaceuticals (PTLA) announced the …
GILEAD & GENMAB To Access Genmab’s (GEN) bispecific antibody technology, Gilead (GILD) signed a new agreement …
Gene Editing EDITAS MEDICINE CRISPR gene editing firm Editas Medicine (EDIT) signed a collaboration agreement with …
Sequenom (SQNM) is no more there as a separate biotech company, as it is on its …
Immunotherapy Engineered T-Cell Therapy Is Here to Stay Articles aimed at undermining the value of the …
We do expect some selling of Array today after AstraZeneca’s announced negative results from Phase 3 …
ANOTHER MISLEADING STORY This article was corrected after being posted. Read our apology at the end …
Investors in the stock market know that stocks yo-yo all the time. Sometimes, the yo-yoing becomes …
EMA’s created Priority Medicines (PRIME) regulatory initiative for products which the European agency rules they are …
The FDA advisory committee members’ inability to rule for or against the approval of Valeant (VRX) …
Important news is the news that informs about successful achievements that make a difference in treating …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
